Form 4 for BCDA BioCardia, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-11 · accession 0001437749-24-031410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-16 | 2024-10-11 | BCDA | McClung David | CFO | F - Tax | $2.65 | -11.6K | 30.0K | -28% | -$30.6K | |
| 2024-10-16 | 2024-10-11 | BCDA | McClung David | CFO | A - Grant | $2.65 | +24.2K | 41.6K | +139% | +$64.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-11 | F | D | 11,565 | $2.65 | 30,008 | D | — | — | (F2) The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person. |
| 2 | Common | Common Stock | 2024-10-11 | A | A | 24,193 | $2.65 | 41,573 | D | — | — | (F1) The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024. |